Similar Search Results

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

Persistent link: https://www.econbiz.de/10012802183

TRIPS flexibilities on patent enforcement : lessons from some developed countries relating to pharmaceutical patent protection

Sarnoff, Joshua D. - 2020

Persistent link: https://www.econbiz.de/10012433661

Entry barriers, personal relationships, and cartel formation : generic drugs in the United States

Cuddy, Emily; Porter, Robert H.; Starc, Amanda; … - In: Cartels diagnosed : new insights on collusion, (pp. 12-43). 2025

Persistent link: https://www.econbiz.de/10015419426

Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market

Cavaliere, Alberto; Moayedizadeh, Ashin - 2022

Persistent link: https://www.econbiz.de/10014232582

Are settlements in patent litigation collusive? : evidence from paragraph IV challenges

Helland, Eric; Seabury, Seth A. - 2016

Persistent link: https://www.econbiz.de/10011476934

Using Stock Price Movements to Estimate the Harm from Anticompetitive Drug Patent Litigation Settlements

Drake, Keith M.; McGuire, Thomas G. - National Bureau of Economic Research - 2024

Drug patent litigation settlements containing brand-to-generic "reverse payments" are a decades old antitrust concern …

Persistent link: https://www.econbiz.de/10015145147

Reverse Payment Settlements im Spannungsfeld zwischen Innovationsförderung und funktionierendem Wettbewerb

Schmid, Markus - 2012

Persistent link: https://www.econbiz.de/10009581545

Evaluating the US Pharmaceutical Patent Policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2022

Persistent link: https://www.econbiz.de/10013309494

Collusion in the US generic drug industry

Clark, Robert; Fabiilli, Christopher Anthony; Lasio, Laura - 2021

We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...

Persistent link: https://www.econbiz.de/10012670921

Entry and patenting in the pharmaceutical industry

Giorgetti, Maria Letizia; Mancusi, Maria Luisa - 2016

Persistent link: https://www.econbiz.de/10011765364